Report Detail
Global miRNA Sequencing and Assay Market Size, Status and Forecast 2019-2025
- RnM3251703 |
- 03 April, 2019 |
- Global |
- 95 Pages |
- QYResearch |
- Service & Software
A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals and some viruses, that functions in RNA silencing and post-transcriptional regulation of gene expression.
In 2018, the global miRNA Sequencing and Assay market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global miRNA Sequencing and Assay status, future forecast, growth opportunity, key market and key players. The study objectives are to present the miRNA Sequencing and Assay development in United States, Europe and China.
The key players covered in this study
Illumina
Thermo Fisher Scientific
Qiagen
Perkinelmer
Takara Bio
Ew England Biolabs
Norgen Biotek Corporation
Rilink Biotechnologies
Exogen
Oxford Nanopore Technologies
Market segment by Type, the product can be split into
Sequencing By Synthesis
Nanopore
Ion Semiconductor Sequencing
Market segment by Application, split into
Clinical Medical
Biological Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global miRNA Sequencing and Assay status, future forecast, growth opportunity, key market and key players.
To present the miRNA Sequencing and Assay development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of miRNA Sequencing and Assay are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global miRNA Sequencing and Assay Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Sequencing By Synthesis
- 1.4.3 Nanopore
- 1.4.4 Ion Semiconductor Sequencing
- 1.5 Market by Application
- 1.5.1 Global miRNA Sequencing and Assay Market Share by Application (2014-2025)
- 1.5.2 Clinical Medical
- 1.5.3 Biological Research
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 miRNA Sequencing and Assay Market Size
- 2.2 miRNA Sequencing and Assay Growth Trends by Regions
- 2.2.1 miRNA Sequencing and Assay Market Size by Regions (2014-2025)
- 2.2.2 miRNA Sequencing and Assay Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 miRNA Sequencing and Assay Market Size by Manufacturers
- 3.1.1 Global miRNA Sequencing and Assay Revenue by Manufacturers (2014-2019)
- 3.1.2 Global miRNA Sequencing and Assay Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global miRNA Sequencing and Assay Market Concentration Ratio (CR5 and HHI)
- 3.2 miRNA Sequencing and Assay Key Players Head office and Area Served
- 3.3 Key Players miRNA Sequencing and Assay Product/Solution/Service
- 3.4 Date of Enter into miRNA Sequencing and Assay Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global miRNA Sequencing and Assay Market Size by Type (2014-2019)
- 4.2 Global miRNA Sequencing and Assay Market Size by Application (2014-2019)
5 United States
- 5.1 United States miRNA Sequencing and Assay Market Size (2014-2019)
- 5.2 miRNA Sequencing and Assay Key Players in United States
- 5.3 United States miRNA Sequencing and Assay Market Size by Type
- 5.4 United States miRNA Sequencing and Assay Market Size by Application
6 Europe
- 6.1 Europe miRNA Sequencing and Assay Market Size (2014-2019)
- 6.2 miRNA Sequencing and Assay Key Players in Europe
- 6.3 Europe miRNA Sequencing and Assay Market Size by Type
- 6.4 Europe miRNA Sequencing and Assay Market Size by Application
7 China
- 7.1 China miRNA Sequencing and Assay Market Size (2014-2019)
- 7.2 miRNA Sequencing and Assay Key Players in China
- 7.3 China miRNA Sequencing and Assay Market Size by Type
- 7.4 China miRNA Sequencing and Assay Market Size by Application
8 Japan
- 8.1 Japan miRNA Sequencing and Assay Market Size (2014-2019)
- 8.2 miRNA Sequencing and Assay Key Players in Japan
- 8.3 Japan miRNA Sequencing and Assay Market Size by Type
- 8.4 Japan miRNA Sequencing and Assay Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia miRNA Sequencing and Assay Market Size (2014-2019)
- 9.2 miRNA Sequencing and Assay Key Players in Southeast Asia
- 9.3 Southeast Asia miRNA Sequencing and Assay Market Size by Type
- 9.4 Southeast Asia miRNA Sequencing and Assay Market Size by Application
10 India
- 10.1 India miRNA Sequencing and Assay Market Size (2014-2019)
- 10.2 miRNA Sequencing and Assay Key Players in India
- 10.3 India miRNA Sequencing and Assay Market Size by Type
- 10.4 India miRNA Sequencing and Assay Market Size by Application
11 Central & South America
- 11.1 Central & South America miRNA Sequencing and Assay Market Size (2014-2019)
- 11.2 miRNA Sequencing and Assay Key Players in Central & South America
- 11.3 Central & South America miRNA Sequencing and Assay Market Size by Type
- 11.4 Central & South America miRNA Sequencing and Assay Market Size by Application
12 International Players Profiles
- 12.1 Illumina
- 12.1.1 Illumina Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 miRNA Sequencing and Assay Introduction
- 12.1.4 Illumina Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.1.5 Illumina Recent Development
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 miRNA Sequencing and Assay Introduction
- 12.2.4 Thermo Fisher Scientific Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.2.5 Thermo Fisher Scientific Recent Development
- 12.3 Qiagen
- 12.3.1 Qiagen Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 miRNA Sequencing and Assay Introduction
- 12.3.4 Qiagen Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.3.5 Qiagen Recent Development
- 12.4 Perkinelmer
- 12.4.1 Perkinelmer Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 miRNA Sequencing and Assay Introduction
- 12.4.4 Perkinelmer Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.4.5 Perkinelmer Recent Development
- 12.5 Takara Bio
- 12.5.1 Takara Bio Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 miRNA Sequencing and Assay Introduction
- 12.5.4 Takara Bio Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.5.5 Takara Bio Recent Development
- 12.6 Ew England Biolabs
- 12.6.1 Ew England Biolabs Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 miRNA Sequencing and Assay Introduction
- 12.6.4 Ew England Biolabs Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.6.5 Ew England Biolabs Recent Development
- 12.7 Norgen Biotek Corporation
- 12.7.1 Norgen Biotek Corporation Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 miRNA Sequencing and Assay Introduction
- 12.7.4 Norgen Biotek Corporation Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.7.5 Norgen Biotek Corporation Recent Development
- 12.8 Rilink Biotechnologies
- 12.8.1 Rilink Biotechnologies Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 miRNA Sequencing and Assay Introduction
- 12.8.4 Rilink Biotechnologies Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.8.5 Rilink Biotechnologies Recent Development
- 12.9 Exogen
- 12.9.1 Exogen Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 miRNA Sequencing and Assay Introduction
- 12.9.4 Exogen Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.9.5 Exogen Recent Development
- 12.10 Oxford Nanopore Technologies
- 12.10.1 Oxford Nanopore Technologies Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 miRNA Sequencing and Assay Introduction
- 12.10.4 Oxford Nanopore Technologies Revenue in miRNA Sequencing and Assay Business (2014-2019)
- 12.10.5 Oxford Nanopore Technologies Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on miRNA Sequencing and Assay . Industry analysis & Market Report on miRNA Sequencing and Assay is a syndicated market report, published as Global miRNA Sequencing and Assay Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of miRNA Sequencing and Assay market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
